Time-to-event clinical trial designs: Existing evidence and remaining concerns.
Saved in:
| Title: | Time-to-event clinical trial designs: Existing evidence and remaining concerns. |
|---|---|
| Authors: | Kerr WT; Department of Neurology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA., Auvin S; Assistance Publique-Hôpitaux de Paris, Service de Neurologie Pédiatrique, Hôpital Robert Debré, Paris, France.; Institut National de la Santé et de la Recherche Médicale NeuroDiderot, Université Paris-Cité, Paris, France.; Institut Universitaire de France, Paris, France., Van der Geyten S; Janssen Research & Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium., Kenney C; Xenon Pharmaceuticals, Burnaby, British Columbia, Canada., Novak G; Janssen Research & Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium., Fountain NB; Department of Neurology, University of Virginia, Charlottesville, Virginia, USA., Grzeskowiak C; Research and New Therapies Program, Epilepsy Foundation of America, Maryland, USA., French JA; Comprehensive Epilepsy Center, New York University, New York City, New York, USA. |
| Source: | Epilepsia [Epilepsia] 2023 Jul; Vol. 64 (7), pp. 1699-1708. Date of Electronic Publication: 2023 May 02. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
